Hemophilia A patients who use Helixate® FS, Antihemophilic Factor
(Recombinant), and their treatment providers can now track treatment progress in
real time, with the HeliTraxSM System,
a state-of-the-art wireless Internet-based data management system. The system allows
for a comprehensive view of a patient's progress, with young patients relaying information
about bleeding events and their use of Helixate® FS to their hemophilia
treatment center via the handheld device or web interface between office visits.
The HeliTraxSM System, used in conjunction
with Helixate® FS treatment, is designed to improve patient-physician
communications and therapy management.
Physicians monitoring hemophilia A patients often rely on paper forms filled out
by the patients or their caregivers, which do not always provide necessary clinical
information in a timely, clear and concise way. HeliTraxSM
not only tracks a patient's therapy as it happens — including medication usage
and inventory — but allows the hemophilia treatment center to generate a one-page,
easy-to-read, full-color clinical report of the patient's progress. These private,
secure reports, which help reduce documentation and transcription errors, are compliant
with both the Joint Commission on Accreditation of Healthcare Organizations (JCAHO)
and the Health Insurance Portability and Accountability Act (HIPAA).
"I love it. As complicated as things are when you have a child with hemophilia,
the HeliTraxSM System just makes
life 150 percent easier."
- Shirley Smith, Hariman, Tennessee
"HeliTraxSM provides clinicians
with the rapid, comprehensive clinical view they need to make assessments about
treatment, it eliminates paperwork and helps to streamline patient data management.
For young patients, HeliTraxSM helps
them keep in touch with their therapy and motivates them to stay on track."
- Jill Leone, RN, CCRP, Hematology Nurse
